Revisiting role of vaccinations in donors, transplant recipients, immunocompromised hosts, travelers and household contacts of stem cell transplant recipients

Allogeneic or autologous hematopoietic stem cell transplantation (HSCT) have become an increasingly common procedure for the treatment of hematological malignancies such as leukemia, lymphoma and multiple myeloma. Following HSCT, risk of opportunistic infectious diseases is high especially within the first few years following transplant [1]. Infections contribute to increased HSCT related morbidity and mortality. Strategies to reduce HSCT related risk of infections include use of prophylactic antimicrobials and the administration of vaccines against expected pathogens.

Source: Biology of Blood and Marrow Transplantation - October 31, 2019 Category: Hematology Authors: Aneela Majeed, Zoey Harris, Eric Brucks, Alyssa Hinchman, Arafat Ali Farooqui, Muhammad Junaid Tariq, Kavin Tamizhmani, Irbaz bin Riaz, Ali McBride, Azka Latif, Vikas Kapoor, Raheel Iftikhar, Sherif Mossad, Faiz Anwer Tags: Review Article Source Type: research